Medwave tests noninvasive BP (blood pressure) monitor in children:
This article was originally published in Clinica
Executive Summary
Medwave's noninvasive device for continuously monitoring blood pressure (BP) could potentially be used to monitor BP in children over four years of age, a US study has revealed. The Vasotrac device, which is FDA-cleared for use on adults only, produced readings that agreed well with oscillometric cuff readings, according to the 74-patient study. However, the St Paul, Minnesota-based company does not recommend using its device in children until clinical validation has been completed.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.